Keywords: Pfizer, Pharmacia, USA, Fraudulent marketing, Bextra

US Court imposes record fine and forfeiture of $1.3 billion for Pfizer unit’s fraudulent marketing of Bextra

Article | 19 October 2009

Print This

Pharmacia & Upjohn, a subsidiary acquired in 2003 by USA-based drug behemoth Pfizer – which has just completed its $68 billion acquisition of ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in